BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/4/2021 1:47:10 PM | Browse: 398 | Download: 813
 |
Received |
|
2021-01-27 13:48 |
|
Peer-Review Started |
|
2021-01-27 13:58 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-30 02:51 |
|
Revised |
|
2021-04-08 16:21 |
|
Second Decision |
|
2021-04-29 07:42 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-04-29 11:29 |
|
Articles in Press |
|
2021-04-29 11:29 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-05-06 23:17 |
|
Typeset the Manuscript |
|
2021-05-21 01:22 |
|
Publish the Manuscript Online |
|
2021-06-04 13:47 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Review |
| Article Title |
Critical review of bone health, fracture risk and management of bone fragility in diabetes mellitus
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Rajan Palui, Subhodip Pramanik, Sunetra Mondal and Sayantan Ray |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sayantan Ray, MBBS, MD, Doctor, Department of Endocrinology, Medica Superspeciality Hospital and Medica Clinic, 127, EM Bypass, Mukundapur, Kolkata 700099, West Bengal, India. sayantan.ray30@gmail.com |
| Key Words |
Diabetes; Fracture risk; Bone mineral density; Microarchitecture; Anti-diabetic drugs; Anti-osteoporosis therapy |
| Core Tip |
Diabetes mellitus, either type 1 or type 2, has adverse effects on bone that translate into an elevated fracture risk. Different pathophysiological mechanisms contribute to poor bone health in patients with diabetes. Diagnosis of bone fragility in diabetic patients is challenging as traditional fracture predictors underestimate fracture risk in this population, contributing to the concept that diabetes affects bone quality. While waiting for further evidence, the prevention and management of bone fragility in diabetes should include identification of patients at risk, correction of modifiable risk factors, appropriate choice of anti-diabetic medications, and use of anti-osteoporosis drugs with proven efficacy. |
| Publish Date |
2021-06-04 13:47 |
| Citation |
Palui R, Pramanik S, Mondal S, Ray S. Critical review of bone health, fracture risk and management of bone fragility in diabetes mellitus. World J Diabetes 2021; 12(6): 706-729 |
| URL |
https://www.wjgnet.com/1948-9358/full/v12/i6/706.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v12.i6.706 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
